Cit-PAB-OH
>97.0%(LC)
- Product Code: 77533
CAS:
1037794-22-1
| Molecular Weight: | 280.33 g./mol | Molecular Formula: | C₁₃H₂₀N₄O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | 123-127°C | Boiling Point: | |
| Density: | Storage Condition: | 2-8°C, stored in inert gas |
Product Description:
Cit-PAB-OH is widely used in the development of antibody-drug conjugates (ADCs), which are targeted cancer therapies. It serves as a linker molecule, connecting the cytotoxic drug to the antibody. This linkage ensures that the drug is delivered specifically to cancer cells, minimizing damage to healthy tissues. The compound's stability in the bloodstream and its ability to release the drug efficiently at the target site make it a crucial component in enhancing the efficacy and safety of ADCs. Its application is pivotal in advancing precision medicine for treating various cancers.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿9,162.00 |
+
-
|
Cit-PAB-OH
Cit-PAB-OH is widely used in the development of antibody-drug conjugates (ADCs), which are targeted cancer therapies. It serves as a linker molecule, connecting the cytotoxic drug to the antibody. This linkage ensures that the drug is delivered specifically to cancer cells, minimizing damage to healthy tissues. The compound's stability in the bloodstream and its ability to release the drug efficiently at the target site make it a crucial component in enhancing the efficacy and safety of ADCs. Its application is pivotal in advancing precision medicine for treating various cancers.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :